BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31917073)

  • 1. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
    Ortoleva J; Shapeton A; Vanneman M; Dalia AA
    J Cardiothorac Vasc Anesth; 2020 Oct; 34(10):2766-2775. PubMed ID: 31917073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxocobalamin as a Rescue Treatment for Refractory Vasoplegic Syndrome After Prolonged Cardiopulmonary Bypass.
    Burnes ML; Boettcher BT; Woehlck HJ; Zundel MT; Iqbal Z; Pagel PS
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):1012-1014. PubMed ID: 27838199
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.
    Armour S; Armour TK; Joppa WR; Maltais S; Nelson JA; Wittwer E
    Anesth Analg; 2019 Jul; 129(1):e1-e4. PubMed ID: 29979199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.
    Cai Y; Mack A; Ladlie BL; Martin AK
    Ann Card Anaesth; 2017; 20(4):462-464. PubMed ID: 28994688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series.
    Wieruszewski PM; Nei SD; Maltais S; Schaff HV; Wittwer ED
    A A Pract; 2018 Aug; 11(4):96-99. PubMed ID: 29634537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?
    Leyh RG; Kofidis T; StrĂ¼ber M; Fischer S; Knobloch K; Wachsmann B; Hagl C; Simon AR; Haverich A
    J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1426-31. PubMed ID: 12830064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
    Carley M; Schaff J; Lai T; Poppers J
    A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of norepinephrine infusion during cardiopulmonary bypass on perioperative changes in lactic acid level (Norcal).
    Khalil MA; El Tahan MR; Khidr AM; Fallatah S; Abohamar AD; Amer MM; Makhdom F; El Ghoneimy Y; Al Bassam B; Alghamdi T; Abdulfattah D
    Perfusion; 2023 Nov; 38(8):1584-1599. PubMed ID: 35994013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass].
    Lehot JJ
    Ann Fr Anesth Reanim; 2012 May; 31 Suppl 1():S18-21. PubMed ID: 22721515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene Blue as an Adjunct to Treat Vasoplegia in Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass: A Literature Review.
    Arevalo VN; Bullerwell ML
    AANA J; 2018 Dec; 86(6):455-463. PubMed ID: 31584419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative Versus Postoperative Hydroxocobalamin for Vasoplegic Shock in Cardiothoracic Surgery.
    Khandekar DA; Seelhammer TG; Mara KC; Stephens EH; Wittwer ED; Wieruszewski PM
    J Cardiothorac Vasc Anesth; 2023 Dec; 37(12):2538-2545. PubMed ID: 37723020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series.
    Shah PR; Reynolds PS; Pal N; Tang D; McCarthy H; Spiess BD
    Can J Anaesth; 2018 May; 65(5):560-568. PubMed ID: 29209927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.
    Javorski MJ; Kerolos MM; Fareed J; Perez-Tamayo RA
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1322-1326. PubMed ID: 29730947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin and methylene blue: alternate therapies in vasodilatory shock.
    Lavigne D
    Semin Cardiothorac Vasc Anesth; 2010 Sep; 14(3):186-9. PubMed ID: 20705641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.
    Evans A; McCurdy MT; Weiner M; Zaku B; Chow JH
    Ann Thorac Surg; 2019 Jul; 108(1):e5-e7. PubMed ID: 30582924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
    Busse LW; Barker N; Petersen C
    Crit Care; 2020 Feb; 24(1):36. PubMed ID: 32019600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.